{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T02:17:25Z","timestamp":1789611445187,"version":"build-2803163510"},"reference-count":10,"publisher":"Oxford University Press (OUP)","issue":"5","license":[{"start":{"date-parts":[[2024,11,14]],"date-time":"2024-11-14T00:00:00Z","timestamp":1731542400000},"content-version":"vor","delay-in-days":87,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100020950","name":"National Science and Technology Council","doi-asserted-by":"publisher","award":["112-2314-B-006-020-MY3"],"award-info":[{"award-number":["112-2314-B-006-020-MY3"]}],"id":[{"id":"10.13039\/501100020950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11102006"],"award-info":[{"award-number":["NCKUH-11102006"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004844","name":"National Cheng Kung University Hospital","doi-asserted-by":"publisher","award":["NCKUH-11209004"],"award-info":[{"award-number":["NCKUH-11209004"]}],"id":[{"id":"10.13039\/501100004844","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010002","name":"the Ministry of Education","doi-asserted-by":"publisher","award":["MOE-111-YSFMN-0005-001-P1"],"award-info":[{"award-number":["MOE-111-YSFMN-0005-001-P1"]}],"id":[{"id":"10.13039\/100010002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2024,10,1]]},"abstract":"<jats:p>Epidermolysis bullosa pruriginosa (EBP) is a form of dystrophic EB associated with severe pruritus and has skewed Th2 inflammation. Our study suggests that JAK inhibitors may offer superior efficacy compared to dupilumab in treating EBP. Moreover, JAK inhibitors downregulate JAK-STAT signalling and Th1\/2 cell differentiation in lesional skin while not in peripheral blood.<\/jats:p>","DOI":"10.1002\/ski2.445","type":"journal-article","created":{"date-parts":[[2024,8,20]],"date-time":"2024-08-20T01:50:05Z","timestamp":1724118605000},"source":"Crossref","is-referenced-by-count":14,"title":["Real-World Experience of Using Dupilumab and Jak Inhibitors to Manage Pruritus in Epidermolysis Bullosa Pruriginosa"],"prefix":"10.1093","volume":"4","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-4615","authenticated-orcid":false,"given":"Ping-Chen","family":"Hou","sequence":"first","affiliation":[{"name":"Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4557-1109","authenticated-orcid":false,"suffix":"Jr.","given":"Wilson","family":"Aala","sequence":"additional","affiliation":[{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5476-5859","authenticated-orcid":false,"given":"Wei-Ting","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3708-9964","authenticated-orcid":false,"given":"John A.","family":"McGrath","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]},{"name":"St John\u2019s Institute of Dermatology, School of Basic and Medical Biosciences, King\u2019s College London , London ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4365-4533","authenticated-orcid":false,"given":"Chao-Kai","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Dermatology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]},{"name":"Institute of Clinical Medicine, College of Medicine, National Cheng Kung University , Tainan ,","place":["Taiwan"]},{"name":"International Center for Wound Repair and Regeneration, National Cheng Kung University , Tainan ,","place":["Taiwan"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2024,8,19]]},"reference":[{"issue":"5","key":"2025112605523083100_ski2445-bib-0001","doi-asserted-by":"publisher","first-page":"617","DOI":"10.1111\/j.1365-2133.1994.tb13109.x","article-title":"Epidermolysis bullosa pruriginosa: dystrophic epidermolysis bullosa with distinctive cliniocopathological features","volume":"130","author":"McGrath","year":"1994","journal-title":"Br J Dermatol"},{"issue":"1","key":"2025112605523083100_ski2445-bib-0002","doi-asserted-by":"publisher","first-page":"133","DOI":"10.1111\/jdv.17671","article-title":"Dystrophic epidermolysis bullosa pruriginosa: a new case series of a rare phenotype unveils skewed Th2 immunity","volume":"36","author":"Darbord","year":"2022","journal-title":"J Eur Acad Dermatol Venereol"},{"issue":"6","key":"2025112605523083100_ski2445-bib-0003","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1111\/bjd.18855","article-title":"Treatment of epidermolysis bullosa pruriginosa-associated pruritus with dupilumab","volume":"182","author":"Shehadeh","year":"2020","journal-title":"Br J Dermatol"},{"issue":"10","key":"2025112605523083100_ski2445-bib-0004","doi-asserted-by":"publisher","first-page":"1243","DOI":"10.1001\/jamadermatol.2021.3174","article-title":"Epidermolysis bullosa pruriginosa treated with baricitinib","volume":"157","author":"Jiang","year":"2021","journal-title":"JAMA Dermatol"},{"issue":"6","key":"2025112605523083100_ski2445-bib-0005","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1111\/1346-8138.16729","article-title":"Successful treatment of epidermolysis bullosa pruriginosa by dupilumab","volume":"50","author":"Wu","year":"2023","journal-title":"J Dermatol"},{"issue":"3","key":"2025112605523083100_ski2445-bib-0006","doi-asserted-by":"publisher","first-page":"441","DOI":"10.1111\/1346-8138.17079","article-title":"Efficacy of oral JAK1 or JAK1\/2 inhibitor for treating refractory pruritus in dystrophic epidermolysis bullosa: a retrospective case series","volume":"51","author":"Kwon","year":"2024","journal-title":"J Dermatol"},{"key":"2025112605523083100_ski2445-bib-0007","doi-asserted-by":"crossref","DOI":"10.1093\/bjd\/ljae110","article-title":"Dominant dystrophic epidermolysis bullosa is associated with glycolytically active GATA3+ Th2 cells which may contribute to pruritus in lesional skin","author":"Aala","year":"2024","journal-title":"Br J Dermatol"},{"issue":"1","key":"2025112605523083100_ski2445-bib-0008","doi-asserted-by":"publisher","first-page":"130","DOI":"10.1016\/j.jaad.2024.01.088","article-title":"Th2 response drives itch in dystrophic epidermolysis bullosa pruriginosa: a case-control study","volume":"91","author":"Papanikolaou","year":"2024","journal-title":"J Am Acad Dermatol"},{"issue":"10","key":"2025112605523083100_ski2445-bib-0009","doi-asserted-by":"publisher","first-page":"e542","DOI":"10.1111\/ijd.16752","article-title":"Dupilumab as a novel therapy for epidermolysis bullosa pruriginosa","volume":"62","author":"Shao","year":"2023","journal-title":"Int J Dermatol"},{"issue":"2","key":"2025112605523083100_ski2445-bib-0010","doi-asserted-by":"publisher","first-page":"e215","DOI":"10.1111\/jdv.18487","article-title":"Epidermolysis bullosa pruriginosa with extensive truncal involvement treated with upadacitinib","volume":"37","author":"Kim","year":"2023","journal-title":"J Eur Acad Dermatol Venereol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/5\/ski2.445\/60660823\/skinhd_4_5_e445.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/4\/5\/ski2.445\/60660823\/skinhd_4_5_e445.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T10:52:39Z","timestamp":1764154359000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/doi\/10.1002\/ski2.445\/7896854"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,19]]},"references-count":10,"journal-issue":{"issue":"5","published-online":{"date-parts":[[2024,8,19]]},"published-print":{"date-parts":[[2024,10,1]]}},"URL":"https:\/\/doi.org\/10.1002\/ski2.445","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2024,10]]},"published":{"date-parts":[[2024,8,19]]},"article-number":"ski2.445"}}